Published in J Clin Oncol on September 01, 1989
Management of carcinomas of the upper gastrointestinal tract. BMJ (1994) 2.12
Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial. Br J Cancer (1999) 1.80
Response to neoadjuvant chemotherapy best predicts survival after curative resection of gastric cancer. Ann Surg (1999) 1.59
Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis. World J Gastroenterol (2010) 1.44
Laparoscopy in the management of gastric adenocarcinoma. Ann Surg (1997) 1.43
Guidelines for the management of oesophageal and gastric cancer. Gut (2002) 1.42
Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study. Br J Cancer (1996) 1.15
Chemotherapy for gastric cancer. World J Gastroenterol (2006) 1.13
Role of staging laparoscopy with peritoneal lavage cytology in the treatment of locally advanced gastric cancer. Gastric Cancer (2007) 1.13
Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials. World J Gastroenterol (2002) 1.12
Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer. Br J Cancer (1996) 1.07
Current strategies in systemic treatment of gastric cancer and cancer of the gastroesophageal junction. J Cancer Res Clin Oncol (2008) 1.05
Low toxic neoadjuvant cisplatin, 5-fluorouracil and folinic acid in locally advanced gastric cancer yields high R-0 resection rate. J Cancer Res Clin Oncol (2003) 0.96
Adjuvant and/or neoadjuvant therapy for gastric cancer? A perspective review. Ther Adv Med Oncol (2015) 0.91
Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer. World J Surg Oncol (2011) 0.90
Intensify standardized therapy for esophageal and stomach cancer in tumor hospitals. World J Gastroenterol (2001) 0.90
Neoadjuvant chemotherapy followed by surgery versus surgery alone for gastric carcinoma: systematic review and meta-analysis of randomized controlled trials. PLoS One (2014) 0.89
Neoadjuvant treatment for gastric cancer. J Gastric Cancer (2013) 0.85
Gastric small cell carcinoma with marked response to neoadjuvant chemotherapy. Int J Clin Oncol (2005) 0.84
Etoposide: current status and future perspectives in the management of malignant neoplasms. Cancer Chemother Pharmacol (1994) 0.83
Chemotherapy for gastric cancer. Gut (1992) 0.81
Role of staging laparoscopy in gastric malignancies - our institutional experience. World J Gastrointest Surg (2012) 0.81
R0 resection in the treatment of gastric cancer: room for improvement. World J Gastroenterol (2010) 0.80
Impact of pretherapeutic routine clinical staging for the individualization of treatment in gastric cancer patients. Langenbecks Arch Surg (2011) 0.79
A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer. Br J Cancer (2016) 0.78
Neo-adjuvant chemo(radio)therapy in gastric cancer: Current status and future perspectives. World J Gastrointest Oncol (2015) 0.78
The efficacy of gastrectomy for large gastric cancer. Int J Clin Oncol (2006) 0.77
Comparison of efficacy of different route of administration of chemotherapy on unresectable, advanced gastric cancer. World J Surg Oncol (2012) 0.77
Comparison between better and poorly differentiated locally advanced gastric cancer in preoperative chemotherapy: a retrospective, comparative study at a single tertiary care institute. World J Surg Oncol (2014) 0.77
Efficacy of docetaxel combined with oxaliplatin and fluorouracil against stage III/IV gastric cancer. World J Gastroenterol (2014) 0.75
A clinical exploration of neoadjuvant chemotherapy with tegafur, gimeracil, and oteracil potassium capsules combined with oxaliplatin for advanced gastric cancer. Int J Clin Exp Med (2015) 0.75
Neoadjuvant Therapy of Gastric Cancer: A Decisive Step Forward. Gastrointest Tumors (2014) 0.75
A Case of Advanced Gastric Cancer with Para-Aortic Lymph Node Metastasis Treated with Preoperative FOLFOX Chemotherapy Followed by Radical Subtotal Gastrectomy and D2 Lymph Node Dissection. Case Rep Oncol (2017) 0.75
S-1 monotherapy as a neoadjuvant treatment for locally advanced gastric cancer. Korean J Intern Med (2008) 0.75
Clinical outcomes according to primary treatment in gastric cancer patients with peritoneal seeding. J Gastric Cancer (2011) 0.75
Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell (1994) 7.39
The plasmid cloning vector pBR325 contains a 482 base-pair-long inverted duplication. Gene (1981) 4.58
E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res (1994) 4.51
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet (1999) 4.36
Classification and phylogeny of hydrogenases. FEMS Microbiol Rev (2001) 4.23
Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg (1993) 3.45
Boerhaave's syndrome: analysis of the literature and report of 18 new cases. Dis Esophagus (1997) 3.06
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol (2001) 2.91
The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem (1998) 2.88
Rhinoviruses infect the lower airways. J Infect Dis (2000) 2.83
Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83
Effect of medical and surgical therapy on aortic dissection evaluated by transesophageal echocardiography. Implications for prognosis and therapy. The European Cooperative Study Group on Echocardiography. Circulation (1993) 2.74
Pylorus-preserving versus standard pancreatico-duodenectomy: an analysis of 110 pancreatic and periampullary carcinomas. Br J Surg (1992) 2.54
Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg (2001) 2.49
Activities and cellular localization of yeast proteases and their inhibitors. Biochem Biophys Res Commun (1974) 2.44
Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff. J Gen Intern Med (1990) 2.44
Diazepam in labour: its metabolism and effect on the clinical condition and thermogenesis of the newborn. Br Med J (1973) 2.42
Locating human quantitative trait loci: guidelines for the selection of sibling pairs for genotyping. Behav Genet (1994) 2.41
The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II. Genes Dev (1997) 2.38
Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation (2001) 2.37
Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry (2000) 2.25
Phase II study of gemcitabine in patients with advanced pancreatic cancer. Br J Cancer (1996) 2.23
MRI-Based Topographic Parcellation of Human Neocortex: An Anatomically Specified Method with Estimate of Reliability. J Cogn Neurosci (1996) 2.22
Recombination of constant and variable modules alters DNA sequence recognition by type IC restriction-modification enzymes. EMBO J (1992) 2.17
Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat Genet (1995) 2.16
NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees. Am J Med Genet (1998) 2.09
Gyri of the human neocortex: an MRI-based analysis of volume and variance. Cereb Cortex (1998) 2.08
Comparison of intravascular ultrasound and angiography in the assessment of myocardial bridging. Circulation (1994) 2.06
Recommendations on stent manufacture, implantation and utilization. Study Group of the Working Group on Coronary Circulation. Eur Heart J (1997) 2.05
Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg (2001) 2.04
Prognostic factors in gastric carcinoma. Results of the German Gastric Carcinoma Study 1992. Cancer (1993) 2.01
[Conservative therapy of coronary heart disease. Conservative measures]. Internist (Berl) (1997) 2.01
Tracheobronchial lesions following oesophagectomy: prevalence, predisposing factors and outcome. Br J Surg (1998) 1.99
Chromosome 1 loci in Finnish schizophrenia families. Hum Mol Genet (2001) 1.95
Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach. A prospective study. Eur Heart J (1988) 1.90
Circular and linear plasmids of Lyme disease spirochetes have extensive homology: characterization of a repeated DNA element. J Bacteriol (1996) 1.87
Summary of FDA antibody-mediated rejection workshop. Am J Transplant (2011) 1.87
Physician orders for life-sustaining treatment (POLST): outcomes in a PACE program. Program of All-Inclusive Care for the Elderly. J Am Geriatr Soc (2000) 1.87
Integrating nature and nurture: implications of person-environment correlations and interactions for developmental psychopathology. Dev Psychopathol (1997) 1.79
Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg (1998) 1.78
Number of lymph node metastases is significantly associated with survival in patients with radically resected carcinoma of the ampulla of Vater. Br J Surg (1995) 1.77
Plasmid analysis and restriction fragment length polymorphisms of chromosomal DNA allow a distinction between Borrelia burgdorferi strains. Zentralbl Bakteriol (1990) 1.77
Pretherapeutic laparoscopic staging in advanced gastric carcinoma. Endoscopy (1999) 1.76
Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg (1994) 1.75
Activation of Gal4p by galactose-dependent interaction of galactokinase and Gal80p. Science (1996) 1.74
Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet (1998) 1.72
Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data. Eur J Nucl Med (2001) 1.71
The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme. Mol Cell Biol (1997) 1.70
Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood. Cytometry (2002) 1.70
Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication. J Gastrointest Surg (1999) 1.69
Summary of the US FDA approval of belatacept. Am J Transplant (2012) 1.68
Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography. Gastroenterology (1992) 1.68
Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles. Leukemia (2011) 1.67
Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. J Biol Chem (1995) 1.67
The 5-HT transporter gene-linked polymorphic region (5-HTTLPR) in evolutionary perspective: alternative biallelic variation in rhesus monkeys. Rapid communication. J Neural Transm (Vienna) (1997) 1.65
Pathophysiology of impaired right and left ventricular function in chronic embolic pulmonary hypertension: changes after pulmonary thromboendarterectomy. Chest (2000) 1.65
Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect Immun (1998) 1.64
Cellular and molecular mechanisms for reduced interleukin 4 and interferon-gamma production by neonatal T cells. J Clin Invest (1991) 1.64
Application of C1-esterase inhibitor during reperfusion of ischemic myocardium: dose-related beneficial versus detrimental effects. Circulation (2001) 1.64
Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol (1984) 1.62
Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol (1999) 1.61
A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol Psychiatry (2010) 1.61
SH3 domain-mediated interaction of dystroglycan and Grb2. J Biol Chem (1995) 1.61
Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus. Br J Surg (2000) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Stented versus nonstented pancreaticojejunostomy after pancreatoduodenectomy: a prospective study. Ann Surg (1999) 1.60
Impact of restenosis 10 years after coronary angioplasty. Eur Heart J (1998) 1.59
Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA. Eur Heart J (2001) 1.58
Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence. Am J Pathol (2000) 1.57
Genome-wide scan in a nationwide study sample of schizophrenia families in Finland reveals susceptibility loci on chromosomes 2q and 5q. Hum Mol Genet (2001) 1.57
Mapping of adenovirus messenger RNA by electron microscopy. Proc Natl Acad Sci U S A (1976) 1.56
Selective defects of T lymphocyte function in patients with lethal intraabdominal infection. Am J Surg (1999) 1.56
Tumour-associated proteolytic factors uPA and PAI-1 and survival in totally resected gastric cancer. Lancet (1994) 1.56
Achalasia and esophageal cancer: incidence, prevalence, and prognosis. World J Surg (2001) 1.55
Exploring the genetic link between RLS and ADHD. J Psychiatr Res (2009) 1.55
Antiphase oscillation of the left and right suprachiasmatic nuclei. Science (2000) 1.54
The superiority of TIMI frame count in detecting coronary flow changes after coronary stenting compared to TIMI Flow Classification. J Invasive Cardiol (2002) 1.54
Cystic enlargement of extrahepatic bile ducts. Surgery (1993) 1.53
Depressive symptomatology in women and residential proximity to high-voltage transmission lines. Am J Epidemiol (1994) 1.53
Measurement of the forward-backward charge asymmetry in top-quark pair production. Phys Rev Lett (2008) 1.53
The role of adherent HLA-DR+ mononuclear cells in autologous and allogeneic MLR. J Immunol (1981) 1.53
Lymphadenectomy in gastric carcinoma. A prospective and prognostic study. Arch Surg (1992) 1.53
Optimization of the antimicrobial activity of magainin peptides by modification of charge. FEBS Lett (2001) 1.52
Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest Endosc (1991) 1.52
Subcellular distribution of yeast invertase isoenzymes. Arch Microbiol (1975) 1.51
Thoracic, but not lumbar, epidural anesthesia improves cardiopulmonary function in ovine pulmonary embolism. Anesth Analg (2001) 1.50
Angiographic follow-up results of a randomized study on angioplasty versus bypass surgery (GABI trial). GABI Study Group. Eur Heart J (1996) 1.50
High-throughput sample handling and data collection at synchrotrons: embedding the ESRF into the high-throughput gene-to-structure pipeline. Acta Crystallogr D Biol Crystallogr (2006) 1.50
Irinotecan in the treatment of colorectal cancer: clinical overview. J Clin Oncol (2001) 1.50
[Comparison of the quality of life after subtotal and total gastrectomy for stomach carcinoma]. Dtsch Med Wochenschr (1996) 1.50
Free peritoneal tumour cells are an independent prognostic factor in curatively resected stage IB gastric carcinoma. Br J Surg (2006) 1.49
Amplification of chloramphenicol resistance transposons carried by phage P1Cm in Escherichia coli. Mol Gen Genet (1979) 1.49